Cátia Moutinho
Cátia Moutinho
Post Doc Researcher
Verified email at cnag.crg.eu
Cited by
Cited by
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk
J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ...
Nature genetics 42 (2), 105, 2010
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function
SA Melo, S Ropero, C Moutinho, LA Aaltonen, H Yamamoto, GA Calin, ...
Nature genetics 41 (3), 365, 2009
A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells
SA Melo, C Moutinho, S Ropero, GA Calin, S Rossi, R Spizzo, ...
Cancer cell 18 (4), 303-315, 2010
Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis
V Davalos, C Moutinho, A Villanueva, R Boque, P Silva, F Carneiro, ...
Oncogene 31 (16), 2062-2074, 2012
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ...
Oncogene 26 (1), 158-163, 2007
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: Primary or secondary genetic events in colorectal carcinogenesis?
S Velho, C Moutinho, L Cirnes, C Albuquerque, R Hamelin, F Schmitt, ...
BMC cancer 8 (1), 255, 2008
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
S Melo, A Villanueva, C Moutinho, V Davalos, R Spizzo, C Ivan, S Rossi, ...
Proceedings of the National Academy of Sciences 108 (11), 4394-4399, 2011
BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes
E Domingo, RC Niessen, C Oliveira, P Alhopuro, C Moutinho, E Espín, ...
Oncogene 24 (24), 3995-3998, 2005
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis
S Moran, A Martínez-Cardús, S Sayols, E Musulén, C Balañá, ...
The Lancet Oncology 17 (10), 1386-1395, 2016
Gene amplification of the histone methyltransferase SETDB1 contributes to human lung tumorigenesis
M Rodriguez-Paredes, AM De Paz, L Simo-Riudalbas, S Sayols, ...
Oncogene 33 (21), 2807-2813, 2014
Tumor-related molecular mechanisms of oxaliplatin resistance
E Martinez-Balibrea, A Martínez-Cardús, A Ginés, VR de Porras, ...
Molecular cancer therapeutics 14 (8), 1767-1776, 2015
Head-to-head antisense transcription and R-loop formation promotes transcriptional activation
R Boque-Sastre, M Soler, C Oliveira-Mateos, A Portela, C Moutinho, ...
Proceedings of the National Academy of Sciences 112 (18), 5785-5790, 2015
Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour
C Oliveira, J de Bruin, S Nabais, M Ligtenberg, C Moutinho, ...
Oncogene 23 (12), 2236-2240, 2004
Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer
A Amatu, A Sartore-Bianchi, C Moutinho, A Belotti, K Bencardino, ...
Clinical cancer research 19 (8), 2265-2272, 2013
Digital PCR quantification of MGMT methylation refines prediction of clinical benefit from alkylating agents in glioblastoma and metastatic colorectal cancer
L Barault, A Amatu, FE Bleeker, C Moutinho, C Falcomata, V Fiano, ...
Annals of oncology 26 (9), 1994-1999, 2015
Epidermal growth factor receptor structural alterations in gastric cancer
C Moutinho, AR Mateus, F Milanezi, F Carneiro, R Seruca, G Suriano
BMC cancer 8 (1), 10, 2008
Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer
A Diaz-Lagares, AB Crujeiras, P Lopez-Serra, M Soler, F Setien, A Goyal, ...
Proceedings of the National Academy of Sciences 113 (47), E7535-E7544, 2016
Mechanisms of therapy resistance in patient-derived xenograft models of BRCA1-deficient breast cancer
P Ter Brugge, P Kristel, E Van Der Burg, U Boon, M De Maaker, E Lips, ...
Journal of the National Cancer Institute 108 (11), djw148, 2016
Linkage of DNA methylation quantitative trait loci to human cancer risk
H Heyn, S Sayols, C Moutinho, E Vidal, JV Sanchez-Mut, OA Stefansson, ...
Cell reports 7 (2), 331-338, 2014
Epigenetic inactivation of the BRCA1 interactor SRBC and resistance to oxaliplatin in colorectal cancer
C Moutinho, A Martinez-Cardús, C Santos, V Navarro-Pérez, ...
JNCI: Journal of the National Cancer Institute 106 (1), 2014
The system can't perform the operation now. Try again later.
Articles 1–20